Clinical Trial Update: Isa-Pom-Dex in Elderly/Frail Subjects With RRMM [Phase 2]

View source ↗

Summary

A Phase 2 trial of isatuximab-pomalidomide-dexamethasone (Isa-Pom-Dex) in elderly or frail patients with relapsed/refractory multiple myeloma; the study is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And Refractory Multiple Myeloma
• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Isatuximab (isatuximab)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Multiple Myeloma, Relapse | Phase 2 | Status: ACTIVE_NOT_RECRUITING